← Leaderboards
Bruce Raphael
New York University School Of Medicine
$21,006
Attributed
$21,006
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$21,006 · 1
By mechanism
M01$21,006 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Howard S Hochster$9,390,994
- Franco M Muggia$5,360,861
- Kwok Kin Wong$31,472,345
- Joan Reibman$39,766,410
- Jay Cooper$168,048
Others in their field
Top investigators on “2'3'Dideoxyinosine”
- Jay B Jackson · Johns Hopkins University$20,808,099
- Stephen J Durako · Westat, Inc.$15,048,684
- Paul E Palumbo · Univ Of Med/Dent Of Nj-Nj Medical School$2,958,155
- Yvonne J Bryson · University Of California Los Angeles$2,935,570
- Gwendolyn B. Scott · University Of Miami School Of Medicine$2,798,352
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$2,750,142
Research focus
2'3'DideoxyinosineAids Related Neoplasm /CancerAids TherapyClinical ResearchColony Stimulating FactorCombination Cancer TherapyCyclophosphamideDoxorubicinDrug Screening /EvaluationEtoposideHiv InfectionsHuman SubjectHuman Therapy EvaluationNonhodgkin'S Lymphoma
Grant awards (4)
CYCLOPHOSPHAMIDE,DOXORUBICIN &ETOPOSIDE +DDI &GCSF IN HIV+ NONHODGKINS LYMPHOMA$0
M01 · FY2002 · RR
CYCLOPHOSPHAMIDE,DOXORUBICIN &ETOPOSIDE +DDI &GCSF IN HIV+ NONHODGKINS LYMPHOMA$0
M01 · FY2001 · RR
CYCLOPHOSPHAMIDE,DOXORUBICIN &ETOPOSIDE +DDI &GCSF IN HIV+ NONHODGKINS LYMPHOMA$21,006
M01 · FY2000 · RR
CYCLOPHOSPHAMIDE,DOXORUBICIN &ETOPOSIDE +DDI &GCSF IN HIV+ NONHODGKINS LYMPHOMA$0
M01 · FY2000 · RR